Search
-
Greece rises through the ranks for LNG transport tankers
EconomyFeaturestankers in 2018 out of 66 new contracts, the majority of which were signed with South Korea, meaning
27% -
Going for Growth: What next for Greece's economy and banks?
Agorahave to move on and become ambitious again – look at post-war Germany and Japan, and South Korea’s...://www.commerzbank.com/en/hauptnavigation/aktionaere/aktie/aktuelle_kursentwicklung/aktuelle
27% -
OECD report traces change in public spending over a decade
EconomyFeaturesinstitutionalised. Greece was one of four countries along with Latvia, Korea and Turkey where exclusive overall
27% -
A virus is spreading across China, but so is the demand for transparency
Agora, namely South Korea. The social consequences of preventing millions of one’s own citizens to move
27% -
Personal responsibility and public healthcare: Greece on a wing and a prayer
Agoraand South Korea. Of course, if he was truly expecting Greeks to show personal responsibility
27% -
On lockdown: The moments that will remain
Agora, while South Korea, Singapore and Hong Kong are among those that have been recognised
27% -
Rival parties interpret Novartis settlement differently, serving own ends
PoliticsGreek PoliticsThe decision taken by drugs giant Novartis to pay 347 mln dollars to US authorities for corrupt practices in Greece, as well as South Korea, Vietnam and China, has added more fuel to the political battle between New Democracy and SYRIZA, which has been raging over the last few days as result
27% -
Data shows export market shake-up amid pandemic
EconomyFeaturesto Japan in the first half of the year raised the country to 22nd place from 42nd place. South Korea
27% -
We can't ignore population shifts within the European Union
Agoraleaving the country. This was notorious under the previous Soviet Union, and still is in North Korea
27% -
Judges' Novartis decision revives political battle over bribery scandal
PoliticsGreek Politicspractices in Greece, as well as South Korea, Vietnam and China. The Swiss pharmaceutical company accepted
27%